Brian Goff - Net Worth and Insider Trading

Brian Goff Net Worth

The estimated net worth of Brian Goff is at least $9 Million dollars as of 2024-12-26. Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc and owns about 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $7 Million. Brian Goff is also the CEO of Agios Pharmaceuticals Inc and owns about 78,792 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $3 Million. Details can be seen in Brian Goff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Goff has not made any transactions after 2024-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brian Goff

To

Brian Goff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Goff owns 3 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Baxalta Inc (BXLT) , and Agios Pharmaceuticals Inc (AGIO) .

Click here to see the complete history of Brian Goff’s form 4 insider trades.

Insider Ownership Summary of Brian Goff

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-06-08 EVP & Chief Commercial Officer
BXLT Baxalta Inc 2016-06-03 EVP and President & Hematology
AGIO Agios Pharmaceuticals Inc 2024-08-08 director & Chief Executive Officer

Brian Goff Latest Holdings Summary

Brian Goff currently owns a total of 2 stocks. Among these stocks, Brian Goff owns 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $7 Million and a weighting of 70.96%. Brian Goff also owns 78,792 shares of Agios Pharmaceuticals Inc (AGIO) as of August 8, 2024, with a value of $3 Million and a weighting of 29.04%.

Latest Holdings of Brian Goff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2018-06-08 36,257 182.50 6,616,903
AGIO Agios Pharmaceuticals Inc 2024-08-08 78,792 34.37 2,708,081

Holding Weightings of Brian Goff


Brian Goff Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Goff has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,645 shares on June 8, 2018, which brought Brian Goff around $194,982.

According to the SEC Form 4 filings, Brian Goff has made a total of 6 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 11,091 shares on August 8, 2024, which brought Brian Goff around $474,140.

Insider Trading History of Brian Goff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Goff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Goff Ownership Network

Ownership Network List of Brian Goff

No Data

Ownership Network Relation of Brian Goff

Insider Network Chart

Brian Goff Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Research & Development John J Orloff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Brian Goff Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Goff. You might contact Brian Goff via mailing address: C/o Alexion Pharmaceuticals, Inc, 100 College Street, New Haven Ct 06510.

Discussions on Brian Goff

No discussions yet.